FREEDOM
2012
Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease
In 1,900 patients with diabetes and multivessel coronary disease, PCI with drug-eluting stents increased death, nonfatal MI, or nonfatal stroke compared with CABG.
Result
- Absolute difference
- 7.9 points
- NNH
- 13
Absolute difference and NNH are derived from the event rates.
Also reported: 5-year primary event rate , favouring CABG, with lower all-cause death and MI but higher stroke (5.2% vs 2.4%).
- Subtopic
- PCI vs CABG
- Design
- Multicentre open-label RCT, superiority
- Relevance
- Important: one of several pillars.
- Source
- Farkouh ME, et al. N Engl J Med. 2012;367(25):2375-84.doi 10.1056/NEJMoa1211585
Discussion & critique
Used first-generation drug-eluting stents and the higher CABG stroke risk is an important trade-off. Definitive evidence that CABG is superior to PCI in diabetics with multivessel disease.